Medikal Retina
Derleme
Printed Date: 4.12.2017
New Developments and New Medicines in Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Abstract
The blood-retina barrier alteration is hallmark feature of diabetic retinopathy. Vascular endothelial growth factor is an important vasopermeability factor that playing role in pathogenesis of blood retina barrier destruction. Inflammation is the second pathology in diabetic retinopathy. New researches are ongoing about both pathways for diabetic retinopathy and macular edema therapy.
Keywords: Diabetic macular edema, VEGF inhibitors, steroids, new medicines
. . .
Article Information
Received : 5.11.2017
Accepted : 4.12.2017
First Published (online): 4.12.2017
Printed : 1.04.2018
Accepted : 4.12.2017
First Published (online): 4.12.2017
Printed : 1.04.2018
Corresponding Author :
Nil İrem UÇGUN : Ankara City Hospital, Ankara, Turkey, Department of Ophthalmology [email protected]
Nil İrem UÇGUN : Ankara City Hospital, Ankara, Turkey, Department of Ophthalmology [email protected]
Citation : Uçgun Nİ, Zeki Fikret C. Diyabetik Retinopati ve Diyabetik Maküla Ödemi Tedavisinde Yeni Gelişmeler ve Yeni İlaçlar. Güncel Retina 2018;2(2):185-188.